Largest pharmaceutical companies in the United States by total assets
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Pfizer leads the 44 pharmaceutical companies in the United States ranked by total assets, at TRY 10.53T, ahead of Johnson & Johnson (TRY 10.08T) and Merck & Co (TRY 6.92T). Figures as of 20 Nov 2026, 08:36 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 44
- First
- PfizerTRY 10.53T
- Median
- TRY 75.5B
- Combined market value
- TRY 188.94T
- Countries
- 1
Market values as of .
United States▾
All sectors▾
Pharmaceuticals▾
| # | Company | Total assets ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | PfizerPFE · Health Care | TRY 10.53T | TRY 7.94T | TRY 1,392.83 | 1.85% down | 15% up | ||
| 2 | Johnson & JohnsonJNJ · Health Care | TRY 10.08T | TRY 32.52T | TRY 13,510.55 | 2.04% down | 34% up | ||
| 3 | Merck & CoMRK · Health Care | TRY 6.92T | TRY 16.56T | TRY 6,716.84 | 3.61% down | 45% up | ||
| 4 | AbbVieABBV · Health Care | TRY 6.78T | TRY 25.35T | TRY 14,339.98 | 0.86% down | 25% up | ||
| 5 | Eli LillyLLY · Health Care | TRY 5.69T | TRY 60.87T | TRY 68,332.62 | 2.29% down | 33% up | ||
| 6 | Bristol-Myers SquibbBMY · Health Care | TRY 4.55T | TRY 6.03T | TRY 2,950.53 | 2.05% down | 30% up | ||
| 7 | Abbott LaboratoriesABT · Health Care | TRY 4.39T | TRY 9.1T | TRY 5,253.20 | 0.58% down | 16% down | ||
| 8 | Regeneron PharmaceuticalsREGN · Health Care | TRY 2.05T | TRY 4.83T | TRY 46,697.74 | 2.35% down | 28% up | ||
| 9 | ViatrisVTRS · Health Care | TRY 1.88T | TRY 1.15T | TRY 1,005.43 | 1.97% down | 99% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | TRY 1.3T | TRY 6.68T | TRY 26,332.28 | 2.94% down | 27% up | ||
| 11 | Royalty PharmaRPRX · Health Care | TRY 992.3B | TRY 1.97T | TRY 3,424.93 | 1.38% down | 79% up | ||
| 12 | ZoetisZTS · Health Care | TRY 782.2B | TRY 1.66T | TRY 4,085.94 | 5.59% down | 26% down | ||
| 13 | Elanco Animal HealthELAN · Health Care | TRY 675.6B | TRY 664.6B | TRY 1,329.61 | 1.54% down | 26% up | ||
| 14 | United TherapeuticsUTHR · Health Care | TRY 398.5B | TRY 1.2T | TRY 28,276.37 | 3.16% down | 22% up | ||
| 15 | BioMarin PharmaceuticalBMRN · Health Care | TRY 384.1B | TRY 601.7B | TRY 3,106.30 | 0.02% down | 17% up | ||
| 16 | Alnylam PharmaceuticalsALNY · Health Care | TRY 251.2B | TRY 1T | TRY 7,475.97 | 1.06% down | 66% down | ||
| 17 | Amneal PharmaceuticalsAMRX · Health Care | TRY 186B | TRY 376.9B | TRY 1,081.79 | 2.24% down | 90% up | ||
| 18 | Ionis PharmaceuticalsIONS · Health Care | TRY 178.2B | TRY 229.3B | TRY 1,376.65 | 0.62% down | 63% down | ||
| 19 | PTC TherapeuticsPTCT · Health Care | TRY 146.6B | TRY 246.4B | TRY 2,949.78 | 3.16% down | 21% down | ||
| 20 | InsmedINSM · Health Care | TRY 114.5B | TRY 1.6T | TRY 7,306.04 | 20.58% up | 40% down | ||
| 21 | Legend BiotechLEGN · Health Care | TRY 87.7B | TRY 157.9B | TRY 814.25 | 0.92% down | 41% down | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | TRY 78.9B | TRY 290.3B | TRY 14,511.93 | 3.94% down | 50% up | ||
| 23 | CytokineticsCYTK · Health Care | TRY 72B | TRY 362.5B | TRY 2,602.58 | 0.27% up | 19% down | ||
| 24 | Arrowhead PharmaceuticalsARWR · Health Care | TRY 70.1B | TRY 312.1B | TRY 2,207.59 | 1.25% up | 13% up | ||
| 25 | Madrigal PharmaceuticalsMDGL · Health Care | TRY 63.7B | TRY 466.1B | TRY 20,065.05 | 0.34% down | 27% down | ||
| 26 | TG TherapeuticsTGTX · Health Care | TRY 53.8B | TRY 496B | TRY 3,281.29 | 1.88% down | 117% up | ||
| 27 | Praxis Precision MedicinesPRAX · Health Care | TRY 47.4B | TRY 439.5B | TRY 15,723.71 | 1.87% up | 86% up | ||
| 28 | Cogent BiosciencesCOGT · Health Care | TRY 47.4B | TRY 244.1B | TRY 1,402.94 | 0.25% down | 20% down | ||
| 29 | BridgeBio PharmaBBIO · Health Care | TRY 47.3B | TRY 770.2B | TRY 3,953.94 | 0.22% up | 21% up | ||
| 30 | Mirum PharmaceuticalsMIRM · Health Care | TRY 42.6B | TRY 315.3B | TRY 4,830.40 | 3.27% up | 34% up | ||
| 31 | Corcept TherapeuticsCORT · Health Care | TRY 42.3B | TRY 359.7B | TRY 3,286.35 | 4.15% down | 10% down | ||
| 32 | Belite BioBLTE · Health Care | TRY 39.5B | TRY 310.2B | TRY 7,637.81 | 3.33% down | 43% up | ||
| 33 | Spyre TherapeuticsSYRE · Health Care | TRY 39.3B | TRY 468.9B | TRY 4,937.62 | 3.77% down | 332% up | ||
| 34 | Summit TherapeuticsSMMT · Health Care | TRY 38B | TRY 427.5B | TRY 534.58 | 0.67% up | 36% down | ||
| 35 | Axsome TherapeuticsAXSM · Health Care | TRY 34.9B | TRY 360.9B | TRY 6,861.99 | 1.25% up | 6% down | ||
| 36 | Protagonist TherapeuticsPTGX · Health Care | TRY 33.8B | TRY 409.4B | TRY 6,272.29 | 2.47% down | 51% up | ||
| 37 | Travere TherapeuticsTVTX · Health Care | TRY 30.6B | TRY 234.5B | TRY 2,442.76 | 3.86% down | 45% up | ||
| 38 | Edgewise TherapeuticsEWTX · Health Care | TRY 27.9B | TRY 228B | TRY 2,082.16 | 0.48% down | 86% up | ||
| 39 | Dianthus TherapeuticsDNTH · Health Care | TRY 26.9B | TRY 241.6B | TRY 4,290.26 | 1.01% up | 108% up | ||
| 40 | Oruka TherapeuticsORKA · Health Care | TRY 24.7B | TRY 334.7B | TRY 4,934.58 | 1.91% up | 255% up | ||
| 41 | Rhythm PharmaceuticalsRYTM · Health Care | TRY 24.3B | TRY 409.5B | TRY 5,907.14 | 1.88% down | 18% up | ||
| 42 | Definium TherapeuticsDFTX · Health Care | TRY 22.3B | TRY 204.1B | TRY 1,490.95 | 1.24% up | 168% up | ||
| 43 | ErascaERAS · Health Care | TRY 20B | TRY 252.4B | TRY 719.17 | 3.34% up | 395% up | ||
| 44 | VeradermicsMANE · Health Care | TRY 7.7B | TRY 265.5B | TRY 6,291.00 | 0.38% down | 231% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 50.5748 TRY).
Questions and answers
Which pharmaceutical companies in the United States rank first by total assets?
Pfizer (TRY 10.53T), Johnson & Johnson (TRY 10.08T) and Merck & Co (TRY 6.92T) are the top three of the 44 pharmaceutical companies in the United States ranked by total assets as of 20 Nov 2026, 08:36 UTC.
How many pharmaceutical companies in the United States are in this ranking?
44 are ranked by total assets.
What are these pharmaceutical companies in the United States worth together?
The 44 pharmaceutical companies in the United States ranked by total assets have a combined market value of TRY 188.94T as of 20 Nov 2026, 08:36 UTC.
What does ranking by total assets measure?
Everything the company owns, as its balance sheet stood at the end of the latest fiscal year.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies in the United States by total assets”, data as of 20 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=united-states&by=total-assets
Underlying data: Yahoo Finance; SEC EDGAR.